Stay updated on Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    This page now shows Revision: v3.5.4, replacing the previous v3.5.3 revision. This indicates a small update to the page record without altering the study details or required actions for participants.
    Difference
    0.1%
    Check dated 2026-05-17T10:46:41.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    This change updates the ClinicalTrials.gov page revision version from v3.5.2 to v3.5.3, reflecting a site/software metadata update rather than a change to the underlying study record content.
    Difference
    0.1%
    Check dated 2026-04-25T18:35:38.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    Site revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:25:47.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    - Version history updated: Revision v3.5.0 added; Revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-21T00:52:23.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    Version bump from v3.4.2 to v3.4.3; study details and user-facing content remain the same.
    Difference
    0.1%
    Check dated 2026-03-06T18:16:21.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    Added 'Gastric cancer' as a keyword and included the Genetic and Rare Diseases Information Center under Resources. Page revision updated from v3.4.1 to v3.4.2.
    Difference
    0.2%
    Check dated 2026-02-13T12:35:09.000Z thumbnail image

Stay in the know with updates to Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Telomelysin+Pembrolizumab in Esophagogastric Adenocarcinoma Clinical Trial page.